Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Credit Suisse upgrades AstraZeneca
Marketwatch
Wednesday, January 13, 2010 - 11:06am
tags:
AstraZeneca, upgrades
PDI Announces Recent Business Wins Totaling $51 million in Revenue for 2010
PharmaLive
Wednesday, January 13, 2010 - 10:52am
tags:
PDI Pharma, contract sales
Genzyme: Most Cerazyme Patients Resume Therapy
Pharmalot
Wednesday, January 13, 2010 - 10:50am
tags:
Genzyme, Gaucher disease, Cerazyme
Merck leads drug stocks higher
Marketwatch
Wednesday, January 13, 2010 - 10:36am
tags:
Merck, drug stocks
Sanofi-Aventis CEO on Pharma’s ‘Lost Decade’
WSJ Online
Wednesday, January 13, 2010 - 9:41am
tags:
Sanofi, Chris Viehbacher, Pharma CEOs
FTC Presses For An End To ‘Pay-To-Delay’ Deals
Pharmalot
Wednesday, January 13, 2010 - 9:36am
tags:
FTC, pay-for-delay, generics
Credit Suisse downgrades GlaxoSmithKline
Marketwatch
Wednesday, January 13, 2010 - 9:34am
tags:
GSK, downgrades
Ahead of the Bell: Merck upgraded on drug pipeline
Yahoo/AP
Wednesday, January 13, 2010 - 9:33am
tags:
Merck, pipelines, upgrades
Pharmaxis buys Topigen in all-stock deal
Fierce Biotech
Wednesday, January 13, 2010 - 9:25am
tags:
Topigen, M&A, Pharmaxis
Dendreon sees full Provenge capacity by mid-2011
Reuters
Wednesday, January 13, 2010 - 9:24am
tags:
Dendreon, prostate cancer, Provenge
Amgen as a Short Candidate
Seeking Alpha
Wednesday, January 13, 2010 - 9:23am
tags:
Amgen
Biogen Idec says Tysabri sales top $1 billion, new patients grow 30 percent
Yahoo/AP
Wednesday, January 13, 2010 - 9:22am
tags:
Biogen Idec, Tysabri, MS, multiple sclerosis
Glaxo to Seek U.S. Approval for Lupus Drug This Year
Bloomberg
Wednesday, January 13, 2010 - 9:20am
tags:
lupus, GSK, Benlysta
Biomedical Research Funding Is Slowing
Pharmalot
Wednesday, January 13, 2010 - 9:19am
tags:
R&D, funding
Big Pharma, Generic Competition and Cash
WSJ Online
Wednesday, January 13, 2010 - 9:15am
tags:
generics, FTC, Big Pharma
SEC Files Insider Trading Suit Against Drug Exec
Pharmalot
Wednesday, January 13, 2010 - 7:54am
tags:
SEC, Indevus, Endo, insider trading
AstraZeneca, Sanofi, Merck Heart Drugs Cut Alzheimer’s Disease
Bloomberg
Wednesday, January 13, 2010 - 7:53am
tags:
Alzheimer's disease, Merck, Sanofi, AstraZeneca, ARBs
Two Strikes for Gilead's Non-HIV Franchises
BNET Pharma
Tuesday, January 12, 2010 - 9:00pm
tags:
Gilead Sciences, darusentan, Ranexa
[video]Diabetes Setback
Yahoo/CNBC
Tuesday, January 12, 2010 - 8:59pm
tags:
MannKind, inhaled insulin, diabetes
Glaxo Exercises Drug Option
Yahoo/Zacks.com
Tuesday, January 12, 2010 - 8:58pm
tags:
GSK, licensing, Merck, Bristol-Myers Squibb, ChemoCentryx

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.